Abstract
Solubility measurement is one of the key elements that need to be considered in drug discovery and development process. Hence, its appropriate analysis and optimization is necessary to enhance the drug’s pharmacokinetic and therapeutic effects. In this article, different methods used for solubility analysis and optimization such as shake flask, potentiometric, turbidimetric, computational, miniature device and high throughput automated methods have been summarized. Additionally, the effect of solubility optimization methods (physical, chemical and carrier technology modifications) on pharmacokinetic enhancement has also been elucidated. New fast, feasible and automated methods of solubility analysis are necessary for its accurate measurement as well as for minimization of errors posed by traditional methods. Among the physical, chemical and carrier modification methods; higher potential is exhibited by nanoparticulate drug delivery carriers for optimization of drug solubility and enhancement of pharmacokinetics. Based on the drug characteristics and delivery requirement, appropriate method can be chosen for efficient solubility and pharmacokinetics enhancement of lipophilic drugs, especially of BCS class II and class IV.
Similar content being viewed by others
References
Alavijeh MS, Chishty M, Qaiser MZ et al (2005) Drug metabolism and pharmacokinetics, the blood–brain barrier, and the central nervous system drug discovery. NeuroRx® 2:554–571
Ale EC, Maggio B, Fanani ML (2012) Ordered-disordered domain coexistence in ternary lipid monolayers activates sphingomyelinase by clearing ceramide from the active phase. Biochim Biophys Acta 1818:2767–2776
Ali HS, York P, Blagden N (2009) Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 375:107–113
Alonzo DE, Zhang GG, Zhou D et al (2010) Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res 27(4):608–618
Amidon GL, Lennernas H, Shah VP et al (1995) A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420
Anwar M, Warsi MH, Mallick N et al (2011) Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats. Eur J Pharm Sci 44:241–249
Atef E, Belmonte AA (2008) Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci 35:257–263
Athawale RB, Jain DS, Singh KK et al (2014) Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. Biomed Pharmacother 68:231–240
Avdeef A, Testa B (2002) Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques. Cell Mol Life Sci 59:1681–1689
Baek HH, Kwon SY, Rho SJ et al (2011) Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Arch Pharm Res 34:391–397
Balani PN, Wong SY, Ng WK et al (2010) Influence of polymer content on stabilizing milled amorphous salbutamol sulphate. Int J Pharm 391:125–136
BergstrÓ§m CA, Norinder U, Luthman K, Artursson P (2002) Experimental and computational screening models for prediction of aqueous drug solubility. Pharm Res19:182–188
Bourkaib N, Zhou J, Yao J et al (2013) Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique. Drug Dev Ind Pharm 39(6):918–927
Čerpnjak K, Zvonar A, Vrečer F et al (2014) Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen. Drug Dev Ind Pharm 13:1–10
Chen XQ, Venkatesh S (2004) Miniature device for aqueous and non-aqueous solubility measurements during drug discovery. Pharm Res 21:1758–1761
Chi L, Liu R, Guo T et al (2015) Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation. Int J Pharm 479:349–356
Chiou WL, Riegelman S (1969) Preparation and dissolution characteristics of several fast-release solid dispersion of griseofulvin. J Pharm Sci 58:1505–1510
Cho JH, Kim YI, Kim DW et al (2014) Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. Eur J Pharm Sci 54:1–7
Cornaire G, Woodley J, Hermann P et al (2004) Impact of excipients on the absorption of p-glycoprotein substrates in vitro and in vivo. Int J Pharm 278:119–131
Custodio JM, Wu CY, Benet LZ (2008) Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 60:717–733
Dahan A, Miller JM (2012) The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J 14:244–251
Detroja C, Chavhan S, Sawant K (2011) Enhanced antihypertensive activity of candesartan cilexitil nanosuspension: formulation, characterization and pharmacodynamic study. Sci Pharm 79:635–651
DiPiro JT, Spruill WJ, Wade WE et al (2010) Concept in clinical pharmacokinetics. American Society of Health-System Pharmacists, Bethesda
Elsayed I, Abdelbary AA, Elshafeey AH (2014) Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomed 9:2943–2953
Erez R, Segal E, Miller K et al (2009) Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. Bioorg Med Chem 17:4327–4335
Gaba B, Fazil M, Ali A et al (2015) Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv 22:691–700
Gershanik T, Benita S (2000) Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 50:179–188
Glomme A, März J, Dressman JB (2005) Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci 94:1–16
Guo B, Zhong S, Li N et al (2013) Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 39:1638–1643
Gupta U, Agashe HB, Jain NK (2007) Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes. J Pharm Pharm Sci 10:358–367
Gupta B, Poudel BK, Tran TH et al (2015) Modulation of pharmacokinetic and cytotoxicity profile of imatinib base by employing nanostructured lipid carriers. Pharm Res 32:2912–2927
Hancock BC, Zografi G (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1–12
Hao HX, Hou BH, Wang JK et al (2005) Solubility of erythritol in different solvents. J Chem Eng Data 50:1454–1456
Hashem FM, Al-Sawahli MM, Nasr M et al (2015) Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems—enhancement of oral bioavailability. Drug Des Dev Ther 9:3141–3152
Hu L, Tang X, Cui F (2004) Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 56:1527–1535
Huang Y, Zhang B, Gao Y et al (2014) Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. J Pharm Sci 103:2330–2337
Humberstone AJ, Charman WN (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25:103–128
Huuskonen J, Salo M, Taskinen J (1998) Aqueous solubility prediction of drugs based on molecular topology and neural network modeling. J Chem Inf Comput Sci 38:450–456
Hwang DH, Kim YI, Cho KH et al (2014) A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity. J Microencapsul 31:619–626
IUPAC (1997) Compendium of chemical terminology. Blackwell, Oxford
Jakki R, Afzal Syed M, Kandadi P et al (2013) Development of a self-microemulsifying drug delivery system of domperidone: in vitro and in vivo characterization. Acta Pharm 63:241–251
Jing-ling T, Jin S, Zhong-Gui H (2007) Emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr Drug Ther 2:85–93
Jouyban-Gharamaleki V, Jouyban-Gharamaleki K, Shayanfar A et al (2015) An automated system for determining drug solubility based on laser monitoring technique. J Lab Autom 20(1):3–9
Junghanns JUA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3:295–310
Kale AA, Vandana BP (2008) Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS Pharm Sci Tech 9:191–196
Kang BK, Lee JS, Chon SK et al (2004) Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73
Kang JH, Oh DH, Oh YK et al (2012) Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm 80:289–297
Karvas E, Ktistis G, Xenakis A et al (2006) Effect of hydrogen bonding interaction on release mechanism of felodipine from nanodispersion with polyvinylpyrrolidone. Eur J Pharm Biopharm 63:103–114
Kathe N, Henriksen B, Chauhan H (2014) Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev Ind Pharm 40:1565–1575
Ke W, Zhao Y, Huang R et al (2008) Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci 97:2208–2216
Khan F, Islam MS, Roni MA et al (2012) Systematic development of self-microemulsifying drug delivery systems of atorvastatin with improved bioavailability potential. Sci Pharm 80(4):1027–1043
Kim DW, Kang JH, Oh DH et al (2012) Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul 29:323–330
Kim GG, Poudel BK, Marasini N et al (2013a) Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 39:1431–1438
Kim MS, Kim JS, Cho WK et al (2013b) Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles. Artif Cells Nanomed Biotechnol 41:85–91
Kim YH, Kim DW, Kwon MS et al (2015) Clopidogrel napadisilate monohydrate loaded surface-modifies solid dispersion: physicochemical characterization and in vivo evaluation. Biol Pharm Bull 38:1033–1040
Kommuru T, Khan M, Reddy I (2001) Self emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212:233–246
Kufe DW, Pollock RE, Weichselbaum RR et al (2003) Holland-Frei cancer medicine. BC Decker, Hamilton
Kumar N, Bansal G, Kumar S et al (2012) Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins. AAPS Pharm Sci Tech 13:863–874
Lachman L, Lieberman H, Kanig JL (1986) The theory and practice of industrial pharmacy. Lea and Febiger, Philadelphia
Law D, Wang W, Schmitt EA et al (2003) Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci 92:505–515
Lee SN, Poudel BK, Tran TH et al (2013) A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution. Arch Pharm Res 36:79–85
Lee DW, Marasini N, Poudel BK et al (2014) Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS). J Microencapsul 31:31–40
Leleux J, Williams RO III (2014) Recent advancements in mechanical reduction methods: particulate systems. Drug Dev Ind Pharm 40:289–300
Li X, Yin Q, Chen W et al (2006) Solubility of hydroquinone in different solvents from 276.65 to 345.10 K. J Chem Eng Data 51:127–129
Li Y, Bi Y, Xi Y et al (2013) Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles. J Drug Target 21(2):188–199
Liu LS, Kim JM, Kim WS (2015) Simple and reliable quartz crystal microbalance technique for determination of solubility by cooling and heating solution. Anal Chem 7:3329–3335
LÓ§bmann K, Laitinen R, Grohganz H et al (2011) Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol Pharm 8:1919–1928
Madan J, Dhiman N, Parmar VK et al (2010) Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics. Cancer Chemother Pharmacol 65:537–548
Marasini N, Tran TH, Poudel BK et al (2013) Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int J Pharm 441:424–432
Maulik JP, Sanjay SP, Natvarlal MP (2010) Self-microemulsifying drug delivery system. Int J Pharm Sci Rev Res 4(29):35
Mezghrani O, Ke X, Bourkaib N et al (2011) Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin. Pharmazie 66:754–760
Milewski M, Pinninti RR, Stinchcomb AL (2012) Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. J Pharm Sci 101:2777–2786
Mishra A, Agrawal S, Pathak K (2012) Naproxen glycine conjugate-synthesis, pharmaceutical preformulation and pharmacodynamic evaluation. Drug Deliv 19:102–111
Mu CF, Balakrishnan P, Cui FD et al (2010) The effects of mixed MPEG-PLA/pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 31:2371–2379
Murdande SB, Pikal MJ, Shanker RM et al (2010) Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci 99:1254–1264
Nair AB, Attimarad M, Al-Dhubiab BE et al (2014) Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin. Drug Deliv 21:540–547
Nielsen LH, Gordon S, Holm R et al (2013) Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Eur J Pharm Biopharm 85:942–951
O’Driscoll CM (2002) Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15:405–415
Patravale VB, Date AA, Kulkarni RM (2004) Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56:827–840
Pokharkar VB, Mandpe LP, Padamwar MN et al (2006) Development, characterization and solubilization of amorphous form of low Tg drug. Powder Technol 167:20–25
Pradhan R, Tran TH, Choi JY et al (2015) Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability. Arch Pharm Res 38:522–533
Puntawee S, Theerasilp M, Reabroi S et al (2015) Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy. Pharm Dev Technol 21:437–444
Ramasamy T, Kim JH, Choi JY et al (2014) pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy. J Mater Chem B 2:6324–6333
Rashid R, Kim DW, ud Din F et al (2015) Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym 130:26–31
Reviakine I, Johannsmann D, Richter RP (2011) Hearing what you cannot see and visualizing what you hear: Interpreting quartz crystal microbalance data from solvated surfaces. Anal Chem 83:8838–8848
Ruell J, Avdeef A (2003) A measured solution. Mod Drug Disc 2003:47–49
Sanka K, Munjulury VS, Mohd AB et al (2014) Enhancement of solubility, dissolution release profile and reduction in ulcerogenecity of piroxicam by inclusion complex with skimmed milk. Drug Deliv 21:560–570
Seo YG, Kim DH, Ramasamy T et al (2013) Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm 452:412–420
Serajuddin AT (2007) Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603–616
Sha X, Wu J, Chen Y et al (2012) Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation. Int J Nanomed 7:705–712
Shaikh SM, Avachat AM (2011) Enhancement of solubility and permeability of candesartan cilexetil by using different pharmaceutical interventions. Curr Drug Deliv 8(4):346–353
Shanmugam S, Baskaran R, Balakrishnan P et al (2011) Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm 79:250–257
Shen Q, Li X, Li W et al (2011) Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion. AAPS Pharm Sci Tech 12:1044–1049
Shevchenko A, Bimbo LM, Miroshnyk I et al (2012) A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior. Int J Pharm 436:403–409
Singh G, Pai RS (2014) Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization. Expert Opin Drug Deliv 11:1023–1032
Singh A, Worku ZA, Van den Mooter G (2011) Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin Drug Deliv 8:1361–1378
Singh B, Singh R, Bandyopadhyay S et al (2013) Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B 101:465–474
Stott PW, Williams AC, Barry BW (1998) Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release 50:297–308
Sun CC (2013) Cocrystallization for successful drug delivery. Expert Opin Drug Deliv 10:201–213
Tao T, Zhao Y, Wu J et al (2009) Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Int J Pharm 367:109–114
Thadkala K, Nanam PK, Rambabu B et al (2014) Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. Int J Pharm Investig 4:131–137
Thakral S, Suryanarayanan R (2015) Salt formation during freeze-drying—an approach to enhance indomethacin dissolution. Pharm Res 32:3722–3731
Tiwari AK (2001) Modification of crystal habit and its role in dosage form performance. Drug Dev Ind Pharm 27:699–709
Tran TH, Poudel BK, Marasini N et al (2013) Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent. Int J Pharm 443:50–57
Tran TH, Ramasamy T, Troung DH et al (2014a) Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. AAPS Pharm Sci Tech 15:1509–1515
Tran TH, Ramasamy T, Troung DH et al (2014b) Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells. Pharm Res 31:1978–1988
Tran TH, Ramasamy T, Cho HJ et al (2014c) Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability. J Nanosci Nanotechnol 14:4820–4831
Truong DH, Tran TH, Ramasamy T et al (2015) Preparation and characterization of solid dispersion using a novel amphiphilic copolymer to enhance dissolution and oral bioavailability of sorafenib. Powder Technol 283:260–265
U.S. Food and Drug Administration (2015) Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. U.S. Food and Drug Administration, Guidance for Industry, Silver Spring. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm128219.html. Accessed 21 July 2015
Van Eerdenbrugh B, Vermant J, Martens JA et al (2009) A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci 98:2091–2103
Vasconcelos T, Costa P (2007) Development of a rapid dissolving ibuprofen solid dispersion. Pharm Sci 16: 676–681
Verma AK, Sachin K (2008) Novel hydrophilic drug polymer nano-conjugates of cisplatin showing long blood retention profile: its release kinetics, cellular uptake and bio-distribution. Curr Drug Deliv 5:120–126
Verma S, Gokhale R, Burgess DJ (2009) A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm 380:216–222
Wang LC, Ding H, Zhao JH et al (2008) Solubility of isonicotinic acid in 4-methylpyridine + water from (287.65 to 361.15) K. J Chem Eng Data 53:2544–2546
Williams HD, Trevaskis NL, Charman SA et al (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499
Xu W, Ling P, Zhang T (2013) Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013:315–340
Yadav AV, Shete AS, Dabke AP et al (2009) Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian J Pharm Sci 71:359–370
Yadav SK, Mishra S, Mishra B (2012) Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation. AAPS Pharm Sci Tech 13:1031–1044
Yan YD, Sung JH, Kim KK et al (2012) Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 422:202–210
Zhang X, Wang H, Zhang T et al (2014) Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug. Eur J Pharm Sci 62:301–308
Zhou X, Zhang X, Ye Y et al (2015) Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Int J Pharm 479:391–398
Zhu JX, Tang D, Feng L et al (2013) Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride. Drug Dev Ind Pharm 39:499–506
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors (R.K. Thapa, H.G. Choi, J.O. Kim, C.S. Yong) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Thapa, R.K., Choi, HG., Kim, J.O. et al. Analysis and optimization of drug solubility to improve pharmacokinetics. Journal of Pharmaceutical Investigation 47, 95–110 (2017). https://doi.org/10.1007/s40005-016-0299-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-016-0299-z